Ceapro is updated and rated Speculative Buy. As an early stage bio tech company, it is not very well suited to analysis by means of looking at earnings and the balance sheet. A good portion of its value lies in products that it has in development and...
Members only content
The content on this page is for members only. If you are a member, log in below. If you are not a member, please Register.